A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model
Condition: Healthy Interventions: Drug: SAGE-217 high dose; Drug: Placebo; Drug: SAGE-217 low dose Sponsor: Sage Therapeutics Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials